Offstream
news

The South African Health Products Regulatory Authority approves the Pfizer-BioNTech COVID-19 vaccine booster dose for people over the age of 18 that can be administered six months after their second dose, as well as immunocompromised people aged above 12 years that can be administered 28 days after their second dose.
2021-12-8

Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant.
2021-08-12

Egypt signs an agreement to purchase 20 million doses of the Sinopharm BBIBP-CorV vaccine and expects a delivery of 500,000 doses this month.
2021-04-20

Georgia receives 100,000 doses of the Sinopharm BBIBP-CorV vaccine. However, vaccination will not begin until the country receives an approval from the World Health Organization.
2021-04-3

Ethiopia receives 300,000 doses of the Sinopharm BBIBP-CorV vaccine.
2021-03-30

Nepal approves the emergency use of the Sinopharm vaccine, which is the second vaccine to be approved in the country.
2021-02-18

Cambodia launches a vaccination campaign against COVID-19 using 600,000 doses of Sinopharm's BBIBP-CorV vaccine. The son of Prime Minister Hun Sen, Hun Manet, and several cabinet ministers are among the first people to get vaccinated.
2021-02-10

The Ministry of Health grants emergency use authorization for China's Sinopharm vaccine.
2021-02-4

Prime Minister Imran Khan launches the vaccination campaign against COVID-19 in Pakistan, with the first dose of Sinopharm's vaccine administered to a doctor in Islamabad.
2021-02-2

Pakistan receives 500,000 doses of Sinopharm's COVID-19 vaccine.
2021-02-1